Brief: Rosetta Genomics Q1 non-gaap loss per share $0.18 excluding items
19/05/2016 13:00
May 19 (Reuters) - Rosetta Genomics Ltd ROSG.O :
* Company's current operations and plans include a
cost-reduction plan should it be unable to raise sufficient
additional capital
* Expects its current cash position will fund operations for
at least next 12 months
* Rosetta genomics reports 2016 first quarter financial
results
* Q1 loss per share $0.20
* Q1 non-gaap loss per share $0.18 excluding items
* Q1 revenue rose 711 percent to $2.6 million
Source text for Eikon: ID:nBw4tDmkga
Further company coverage: ROSG.O
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics